ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp - Dec 7, 2022 Form 4 Insider Report for Apollo Medical Holdings, Inc. (AMEH)

Role: 10%+ Owner
Signature: /s/ Thomas S. Lam, Chief Executive Officer
Stock symbol: AMEH
Transactions as of: Dec 7, 2022
Transactions value $: $1,128,252
Form type: 4
Date filed: 12/9/2022, 05:43 PM
Previous filing: Dec 6, 2022
Next filing: Nov 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMEH	Common Stock	Options Exercise	$553K	+55.3K	+0.54%	$10.00	10.2M	Dec 7, 2022	Direct	F1
transaction	AMEH	Common Stock	Options Exercise	$575K	+52.3K	+0.51%	$11.00	10.3M	Dec 7, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMEH	Warrants to purchase Common Stock	Options Exercise		-55.3K	-100%		0	Dec 7, 2022	Common Stock	55.3K	$10.00	Direct	F2
transaction	AMEH	Warrants to purchase Common Stock	Options Exercise		-52.3K	-100%		0	Dec 7, 2022	Common Stock	52.3K	$11.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person.
F2	On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share.

Content

These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person.

On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share.